BAGSVAERD, DENMARK -- (Marketwire) -- 01/02/13 -- In continuation of the company's
announcements dated 9 August 2012 and 9 November 2012 concerning planned
share repurchase programmes, and pursuant to Section 204.25 of the New York
Stock Exchange Listed Company Manual, this is to report that Novo Nordisk
A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2012 owned
17,416,676 of its own B shares of DKK 1, corresponding to a total nominal
value of DKK 17,416,676 or 3.1% of the total share capital.